Modulation of immunostimulatory properties by small oligonucleotide-based compounds

Details for Australian Patent Application No. 2004304770 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Agrawal, Sudhir; Kandimalla, Ekambar R.; Zhu, Fu-Gang

Agent Freehills

Pub. Number AU-B-2004304770

PCT Pub. Number WO2005/060377

Priority 60/528,277 08.12.03 US

Filing date 24 May 2004

Wipo publication date 7 July 2005

Acceptance publication date 6 May 2010

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/060377 Priority application(s): WO2005/060377

21 September 2006 Assignment before Grant

  Hybridon, Inc. The application has been assigned to Idera Pharmaceuticals, Inc. 2005

6 May 2010 Application Accepted

  Published as AU-B-2004304770

2 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004304773-Disposable scrubbing product

2004304767-Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein